PP
The startup develops topical therapeutic drugs targeting inflammatory ophthalmic diseases, utilizing specialized formulations to enhance drug delivery to affected tissues. This approach addresses the need for effective treatments for patients suffering from conditions that currently lack adequate therapeutic options.
Updated 3 months ago
Funding
$960K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops topical therapeutic drugs targeting inflammatory ophthalmic diseases, utilizing specialized formulations to enhance drug delivery to affected tissues. This approach addresses the need for effective treatments for patients suffering from conditions that currently lack adequate therapeutic options.